These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Peroxiredoxin II Is Essential for Maintaining Stemness by Redox Regulation in Liver Cancer Cells. Kwon T, Bak Y, Park YH, Jang GB, Nam JS, Yoo JE, Park YN, Bak IS, Kim JM, Yoon DY, Yu DY. Stem Cells; 2016 May; 34(5):1188-97. PubMed ID: 26866938 [Abstract] [Full Text] [Related]
3. Stat3/Oct-4/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066. Cheng CC, Shi LH, Wang XJ, Wang SX, Wan XQ, Liu SR, Wang YF, Lu Z, Wang LH, Ding Y. Int J Oncol; 2018 Jul; 53(1):339-348. PubMed ID: 29750424 [Abstract] [Full Text] [Related]
7. MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer. Jiang J, Li Z, Yu C, Chen M, Tian S, Sun C. Cancer Lett; 2015 Jan 28; 356(2 Pt B):962-70. PubMed ID: 25444909 [Abstract] [Full Text] [Related]
8. SOX2 plays a critical role in EGFR-mediated self-renewal of human prostate cancer stem-like cells. Rybak AP, Tang D. Cell Signal; 2013 Dec 28; 25(12):2734-42. PubMed ID: 24036214 [Abstract] [Full Text] [Related]
12. MYC Regulates the HIF2α Stemness Pathway via Nanog and Sox2 to Maintain Self-Renewal in Cancer Stem Cells versus Non-Stem Cancer Cells. Das B, Pal B, Bhuyan R, Li H, Sarma A, Gayan S, Talukdar J, Sandhya S, Bhuyan S, Gogoi G, Gouw AM, Baishya D, Gotlib JR, Kataki AC, Felsher DW. Cancer Res; 2019 Aug 15; 79(16):4015-4025. PubMed ID: 31266772 [Abstract] [Full Text] [Related]
14. EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer. Singh S, Trevino J, Bora-Singhal N, Coppola D, Haura E, Altiok S, Chellappan SP. Mol Cancer; 2012 Sep 25; 11():73. PubMed ID: 23009336 [Abstract] [Full Text] [Related]
15. Resveratrol suppresses migration, invasion and stemness of human breast cancer cells by interfering with tumor-stromal cross-talk. Suh J, Kim DH, Surh YJ. Arch Biochem Biophys; 2018 Apr 02; 643():62-71. PubMed ID: 29477771 [Abstract] [Full Text] [Related]
16. Sunitinib but not VEGF blockade inhibits cancer stem cell endothelial differentiation. Brossa A, Grange C, Mancuso L, Annaratone L, Satolli MA, Mazzone M, Camussi G, Bussolati B. Oncotarget; 2015 May 10; 6(13):11295-309. PubMed ID: 25948774 [Abstract] [Full Text] [Related]